1. Home
  2. MUSA vs GKOS Comparison

MUSA vs GKOS Comparison

Compare MUSA & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Murphy USA Inc.

MUSA

Murphy USA Inc.

SELL

Current Price

$535.93

Market Cap

9.5B

ML Signal

SELL

Logo Glaukos Corporation

GKOS

Glaukos Corporation

SELL

Current Price

$244.34

Market Cap

9.7B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MUSA
GKOS
Founded
1996
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
9.7B
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
MUSA
GKOS
Price
$535.93
$244.34
Analyst Decision
Buy
Strong Buy
Analyst Count
11
13
Target Price
★ $616.00
$242.46
AVG Volume (30 Days)
265.8K
★ 1.5M
Earning Date
10-28-2026
10-28-2026
Dividend Yield
★ 0.53%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 28.09
N/A
Revenue
★ $21,529,400,000.00
$507,442,000.00
Revenue This Year
$45.07
$53.82
Revenue Next Year
N/A
$28.60
P/E Ratio
$19.30
★ N/A
Revenue Growth
N/A
★ 32.33
52 Week Low
$354.90
$87.32
52 Week High
$636.05
$255.19

Technical Indicators

Market Signals
Indicator
MUSA
GKOS
Relative Strength Index (RSI) 54.51 66.85
Support Level $489.90 $143.30
Resistance Level $543.59 $255.19
Average True Range (ATR) 18.45 14.15
MACD 2.03 1.46
Stochastic Oscillator 74.87 85.89

Price Performance

Historical Comparison
MUSA
GKOS

About MUSA Murphy USA Inc.

Murphy USA Inc is mainly engaged in the marketing of retail motor fuel products and convenience merchandise through a network of several retail stores in the Southwest, Southeast, Midwest, and Northeast United States. The majority of Murphy USA's stores are located in proximity to Walmart Supercenters, but it also operates standalone stores that market gasoline and other products under the Murphy USA, Murphy Express, and QuickChek brands. In addition, the company also markets fuel to unbranded wholesale customers through a mixture of company-owned and third-party product distribution terminals and pipeline positions. The firm generates maximum revenue through retail sales of petroleum products, and the rest from merchandise sales and wholesale of petroleum products.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: